India’s second biggest pharmaceutical company Lupin said it has launched the generic version of Valeant’s Wellbutrin antidepressant tablet Wellbutrin XL in the US. Wellbutrin XL tablet has yearly US sales of USD 758 million or about Rs 5,000 cr. It is used for the treatment of major depressive disorder (MDD) and prevention of seasonal affective […]
Pharma Major Lupin said received final approval for launching a generic version of Mallinckrodt Inc.’s Roxicodone Tablets in the United States. The drug is used for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate, the company said. Roxicodone Tablets has US sales of USD 344 […]
Pharma major Lupin Limited said it launched Iron Isomaltoside injectable iron formulation under two brand names “Isofer” and “Jilazo” in India. Lupin acquired the exclusive rights to market, distribute and sell the injectable formulation from Denmark based Pharmacosmos A/S. The product is currently marketed in 33 countries, including 21 European Union countries under the brand […]
Pharma Major Lupin Ltd. said its US subsidiary, Lupin Pharmaceutical Inc., has agreed to license technology from Monosol Rx to develop multiple paediatric-focused products. Lupin would develop the pediatric products utilizing MonoSol Rx’s proprietary PharmFilm drug delivery technology. MonoSol Rx’s PharmFilm technology is a drug delivery platform that provides precision dosing in the form of […]
Pharma Major Lupin Limited (Lupin) announced that it received tentative approval from the United States Food and Drug Administration (FDA) for selling Silodosin capsules, a generic version of Allergan Sales’ Rapaflo capsules. Silodosin capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia, or the enlargement of tissue due to […]
Pharma Major Lupin Limited announced that its US subsidiary, Gavis Pharmaceuticals LLC., received tentative approval for selling a generic version of Pfizer Inc.’s Zithromax oral suspension from the US FDA. Lupin had earlier received final approval for its Azithromycin Tablets and Azithromycin for Oral Suspension, filed from its Goa plant. Azithromycin per bottle are the […]
Indian pharma major Lupin Ltd announced today that it received tentative approval from the United States Food & Drug Administration to market a generic version of Apotex Technology’s ‘Paxil’ Paroxetine tablets. The medicine is indicated for the treatment of major depressive disorder, panic disorder, social anxiety disorder and premenstrual dysphoric disorder. Tentative FDA approvals do not […]
Pharma Major Lupin Limited announced today that its US subsidiary, Gavis Pharmaceuticals has received final approval for its Linezolid Tablets from the United States Food and Drug Administration (FDA). The drug is a generic equivalent of Pharmacia & Upjohn Company’s Zyvox Tablets, 600 mg. Zyvox Tablets had US sales of USD 273.6 million the company […]
Lupin Ltd announced today that it has received approval to launch Acotiamide 100 mg indigestion tablets in India from the Central Drugs Standard Control Organization. Acotiamide is a drug to be introduced into the Indian Pharmaceutical Market which could benefit millions of patients suffering from Dyspepsia or Indigestion, most common stomach complaints encountered in clinical […]
Lupin Ltd announced today that its US subsidiary, Gavis Pharmaceuticals LLC, has received final approval for its Potassium Chloride Extended-Release Capsules USP, 8 mEq (600 mg) and 10 mEq (750 mg) from the United States Food and Drug Administration (FDA). The capsule is for the treatment of patients with hypokalemia, or the deficiency of potassium […]
